- selective, high
efficacy 5-HT4
receptor serotonin agonist being developed by
Theravance Biopharma and Alfa W****ermann.
Velusetrag demonstrates less selectivity...
-
Administration (FDA)
issued an
approvable letter for telavancin. Its developer,
Theravance,
submitted a
complete response to the letter, and the FDA has ****igned...
-
discovered by
researchers at GlaxoSmithKline, also
known as (GSK), and
Theravance, Inc. (NASDAQ: THRX).
Research first began in 2006, however, its final...
- was
approved for use in the
United States in 2018. It was
developed by
Theravance Biopharma and is
marketed by Mylan.
Revefenacin is
formulated as a solution...
-
Vibativ (telavancin) –
bactericidal lipoglycopeptide –
marketed with
Theravance.
Xospata (gilteritinib) – AXL
receptor tyrosine kinase Xtandi (enzalutamide)...
- (5): 587–594. doi:10.1093/ageing/afs061. PMID 22591985. "Ampreloxetine -
Theravance Biopharma". AdisInsight. 21
November 2023.
Retrieved 26
September 2024...
- 1007/s40262-020-00918-7. PMC 7808980. PMID 32856281. "Ampreloxetine -
Theravance Biopharma". AdisInsight. 21
November 2023.
Retrieved 26
September 2024...
- (Press release).
October 2021.
Retrieved 2021-11-29. "
Theravance Biopharma Pipeline".
Theravance pipeline background image.
Retrieved 2024-02-12. "Pipeline"...
- (developmental code name TD-1211) is a drug
which is
under development by
Theravance Biopharma and
licensed to
Glycyx for all indications. It acts as a peripherally...
-
Conservatory of
Music President’s
Advisory Council,
Vertex Pharmaceuticals,
Theravance, AnorMed,
Idera Pharmaceuticals,
Phase Forward and VaxGen. An amateur...
